Certara, Inc. (NASDAQ:CERT) Receives $20.06 Average Target Price from Brokerages

Shares of Certara, Inc. (NASDAQ:CERT) have received a consensus rating of “Hold” from the eleven brokerages that are currently covering the firm, Marketbeat Ratings reports. Seven investment analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The average 12-month price objective among analysts that have covered the stock in the last year is $20.06.

A number of equities research analysts have weighed in on the stock. Jefferies Financial Group lifted their price target on shares of Certara from $14.00 to $15.50 and gave the stock a “hold” rating in a research note on Friday, March 1st. JMP Securities started coverage on shares of Certara in a research note on Thursday, April 4th. They issued a “market perform” rating on the stock. Leerink Partnrs restated a “market perform” rating on shares of Certara in a research note on Monday, February 26th. UBS Group upped their price objective on Certara from $17.00 to $20.00 and gave the company a “neutral” rating in a research note on Friday, March 1st. Finally, KeyCorp raised Certara from a “sector weight” rating to an “overweight” rating and set a $23.00 target price for the company in a report on Wednesday, April 10th.

Insider Buying and Selling at Certara

In related news, insider Patrick F. Smith sold 14,427 shares of the company’s stock in a transaction dated Tuesday, April 2nd. The shares were sold at an average price of $16.85, for a total transaction of $243,094.95. Following the transaction, the insider now owns 50,091 shares in the company, valued at approximately $844,033.35. The sale was disclosed in a filing with the SEC, which can be accessed through this link. In other news, SVP Richard M. Traynor sold 3,000 shares of Certara stock in a transaction on Monday, April 1st. The stock was sold at an average price of $18.00, for a total value of $54,000.00. Following the completion of the sale, the senior vice president now directly owns 173,524 shares of the company’s stock, valued at approximately $3,123,432. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Patrick F. Smith sold 14,427 shares of the company’s stock in a transaction on Tuesday, April 2nd. The shares were sold at an average price of $16.85, for a total value of $243,094.95. Following the transaction, the insider now directly owns 50,091 shares in the company, valued at approximately $844,033.35. The disclosure for this sale can be found here. Corporate insiders own 2.39% of the company’s stock.

Institutional Trading of Certara

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Pineridge Advisors LLC acquired a new position in Certara in the fourth quarter valued at approximately $28,000. Global Retirement Partners LLC raised its holdings in shares of Certara by 5,306.3% in the first quarter. Global Retirement Partners LLC now owns 1,730 shares of the company’s stock valued at $31,000 after purchasing an additional 1,698 shares during the last quarter. YHB Investment Advisors Inc. bought a new stake in shares of Certara in the first quarter worth $47,000. Covestor Ltd boosted its holdings in Certara by 14,940.0% during the third quarter. Covestor Ltd now owns 3,760 shares of the company’s stock worth $55,000 after purchasing an additional 3,735 shares during the last quarter. Finally, Gamco Investors INC. ET AL bought a new position in Certara in the third quarter valued at $145,000. 73.96% of the stock is owned by institutional investors.

Certara Trading Up 1.2 %

Shares of CERT stock opened at $16.73 on Monday. The company has a current ratio of 3.26, a quick ratio of 3.26 and a debt-to-equity ratio of 0.27. Certara has a 1 year low of $11.81 and a 1 year high of $22.65. The firm’s fifty day simple moving average is $17.19 and its 200 day simple moving average is $16.74. The firm has a market capitalization of $2.69 billion, a P/E ratio of -42.90, a price-to-earnings-growth ratio of 5.72 and a beta of 1.61.

Certara (NASDAQ:CERT) last announced its quarterly earnings data on Thursday, February 29th. The company reported $0.05 EPS for the quarter, missing analysts’ consensus estimates of $0.09 by ($0.04). Certara had a negative net margin of 17.02% and a positive return on equity of 4.08%. The company had revenue of $88.01 million for the quarter, compared to analyst estimates of $86.80 million. As a group, sell-side analysts predict that Certara will post 0.29 EPS for the current year.

Certara Company Profile

Certara, Inc, together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics.